M&A

当事務所は、金融サービス、製造業、貿易、エネルギー・鉱業、自動車、不動産・建築、交通・運輸、ライフサイエンス・医療、食品・飲食業、カルチャー・エンターテイメント・スポーツ、電気通信、メディア及びハイテク等の幅広い産業における外資参入、国外投資、業界規制、国有資産管理、税務、外貨規制、知的財産、労働、独占禁止及び国家安全審査等の各分野の取扱い経験があります。

 

当事務所は中国M&A取引における数々の先例となる案件を処理してきました。

• In 2019, represented New Frontier Corporation to purchase United Family Healthcare (UFH) from TPG
• In 2019, represented Suning.com to acquire Carrefour China
• In 2019, represented Jiangxi Copper Company Limited's acquisition of the Canadian Listed Company First Quantum Minerals Ltd. Shares with a Consideration Exceeding USD 1.1 Billion
• In 2019, represented BeiGenes's Strategic Oncology Collaboration with Amgen
• In 2017, represented CNAC to acquire all the shares of Syngenta (listed in Switzerland and the U.S.) with a deal value of USD42.6 billion (the largest overseas investment acquisition project among Chinese companies, “Outbound Deal of the Year” by China Law & Practice 2017)
• In 2016, participated in IDG Capital's acquisition of shares of A shares listed company Sichuan Shuangma Cement Co., Ltd. and the takeover of control project
• In 2015, represented IFC regarding the strategic investment in Postal Savings Bank of China
• In 2014, represented HKEX-listed company Skyworth Digital Holdings Ltd. injected spin-off domestic STB business (estimated RMB3.5 billion) into China Resources Jinhua Co., Ltd. and listed domestically (The first case of back-door listing of overseas red chip listed company's spin-off domestic asset business at A shares securities market)
• In 2010, represented United Design Group on its overall consolidation with AsiaInfo (ASIA.Nasdaq) (The new company becomes the largest telecom software enterprise in China), and the afterwards listed in Hong Kong
• In 2009, represented Tianjin Port Development Holdings Limited (3382.HK), through its wholly-owned subsidiary Grand Point Investment Limited, acquired 56.81% shares in Tianjin Port Holdings Co., Ltd. (600717.SH) from Tianjin Port (Group) Co., Ltd. for a total consideration of HK$10,961 million (The first state-owned red chip company listed in Hong Kong to acquire the controlling interest in an A-share company listed in China by means of a reverse takeover)
• In 2002, represented SABMiller regarding its general offer to acquire Harbin Brewery Group Harbin Brewery (The first foreign general offer targeting Chinese companies on the Hong Kong Stock Exchange)
• Participated in the share swap absorption merger of Huabei Expressway (000916) and China Merchants Expressway Network & Technology Holdings Co., Ltd.
• Participated in Hubei Shalunda Co., Ltd. RMB18.4 billion share swap to acquire full stake in Adama Agricultural Solutions (the world's sixth-largest pesticide producer)

企業法務

当事務所は、企業法務について、設立から清算までの全過程の実務経験を豊富に有しています。同分野において主に下記の業務を取扱っています。

• 投資スキーム及びコーポレートガバナンススキームの提案
• 法務デューデリジェンス
• 商談・交渉への参加、会社設立関連文書の作成、レビュー、修正
• 各種行政手続サポート
• タックスプランニング、知財保護、労務管理、外貨、税関対応及び出口戦略等への助言
• 企業の日常運営における各種契約書の作成、レビュー及び交渉
• 訴訟及び仲裁に関するサポート
• 組織再編、決済及び清算等に関するサポート

外部機構・団体からの評価

受賞歴

Awards

• 2025, Chambers Greater China Region Awards 2025 - Nomination: Corporate and Finance Law Firm of the Year, Chambers Greater China Region
• 2024, The Legal 500 China Awards 2024 - Nomination: Deal of the year - Corporate & M&A, The Legal 500
• 2022-2025, Nominated in China Law Awards - Corporate M&A Law Firm of the Year, LEGALBAND
• 2024, Nominated in Regional Impact Deals: Beijing - M&A - COFCO Fortune secures $2.9 billion investment, IFLR1000 China
• 2024, Nominated in Regional Impact Deals: Sichuan - Finance and Corporate - Shudao Investment Group acquisition of 50% stake in property insurance company, IFLR1000 China
• 2021-2023, Nominated in Team of the Year - M&A, IFLR1000 China
• 2023, Nominated in Regional Impact Deals: Shanghai - M&A - Full-Life Technologies to Acquire Focus-X Therapeutics, IFLR1000 China
• 2023, Nominated in Regional Impact Deals: Shanghai - M&A - Jemincare to cooperate with Orion on new non-opioid analgesic drug, IFLR1000 China
• 2023, Nominated in Regional Impact Deals: Guangdong - Finance and corporate - Luxshare acquires shares of Chery Holding Group, IFLR1000 China
• 2022, Nominated in Regional Impact Deals: Shanghai - M&A - Shanghai Pharmaceuticals EUR18 million acquisition of Fimet Oy, IFLR1000 China
• 2024, Nominated in M&A Deal of the Year – Midsize: CMET Acquires Road King's Highway Assets, Asian Legal Business
• 2024, Nominated in M&A Deal of the Year: East China  - Sinovac Biotech Acquires Majority Shares in a Biotech Company, Asian Legal Business
• 2024, Nominated in M&A Deal of the Year: South China & Central China: Luxshare Acquires Controlling Interest of Pegaglobe, Asian Legal Business
• 2023, Nominated in M&A Deal of the Year – Midsize: ESR and one global leading institutional investor acquired 11-asset portfolio from US-based DLJ Real Estate, Asian Legal Business
• 2023, Nominated in M&A Deal of the Year: East China – A Huzhou Group's a Bankruptcy Reorganization Investment in Wuyang Construction Group, Asian Legal Business
• 2023, Nominated in M&A Deal of the Year: South China & Central China  - Luxshare and Chery Strategic Business Cooperation and Equity Investment, Asian Legal Business
• 2022, Nominated in M&A Deal of the Year: East China – Primavera Capital Acquires Greater China Business of Mead Johnson from Reckitt Benckiser Group, Asian Legal Business
• 2022, Nominated in M&A Deal of the Year: South China & Central China - SF's HKD 18 billion acquisition of Kerry Logistics, Asian Legal Business
• 2021, Nominated in M&A Deal of the Year – Midsize: LuxsanTech’s acquisition of Two Subsidiaries of Wistron Corporation, Asian Legal Business
• 2020, M&A Deal of the Year – Midsize: “Carrefour's disposal of 80% equity stake in Carrefour China to Suning”, Asian Legal Business
• 2014, 2017-2020, Nominated in M&A Deal of the Year for several times, Asian Legal Business
• 2020, Nominated in M&A Deal of the Year – Midsize: “Jiangxi Copper Company Limited's acquisition of the Canadian Listed Company First Quantum Minerals Ltd. Shares with a Consideration Exceeding USD 1.1 Billion”, “New Frontier Corporation in Acquisition of United Family Healthcare” and “Carrefour's disposal of 80% equity stake in Carrefour China to Suning”, Asian Legal Business
• 2020, Nominated in M&A Deal of the Year – Premium: “BeiGenes's Strategic Oncology Collaboration With Amgen”, Asian Legal Business
• 2014-2016, Nominated in three consecutive years in M&A/Private Equity Law Firm of the Year, Asian Legal Business
• 2004-2013, Nominated in Recommended firm in M&A/Private, Asian Legal Business
• 2020, Deals of The Year - M&A: “New Frontier Corporation in Acquisition of United Family Healthcare”, China Law & Practice
• 2024, Deals of the Year for Infore acquires Kuka Home, Tsinghua Unigroup ups stake in H3C, China Business Law Journal
• 2024 China Outbound Deals Award (Latin American): Brazil - CanSino’s covid-19 vaccine exports, CGN Brazil receives investment, China Business Law Journal
• 2022, China Business Law Awards: M&A (Inbound and domestic), China Business Law Journal
• 2022, Deals of the Year for ESR purchase of USD800M logistics assets from DLJ, China Business Law Journal
• 2020, Deals of the Year for Amgen Acquires BeiGene Stake, China Business Law Journal
• 2020, Deals of the Year for Chinese Consortium’s Investment in Turkey Road Project, China Business Law Journal
• 2020, Deals of the Year for Kazakhstan Boguty Tungsten Mine’s Equity and Debt Financing Project, China Business Law Journal
• 2019, Deals of the Year for NFC acquires United Family Healthcare, China Business Law Journal
• 2019, Deals of the Year for Suning acquires Carrefour China, China Business Law Journal

Rankings

• 2022-2025, Recommended firm in Corporate/M&A, Chambers and Partners Greater China Region
• 2024-2025, Recommended firm in Corporate/Commercial: Guangdong: Non-contentious, Chambers and Partners Greater China Region
• 2025, Recommended firm in Corporate/Commercial: Sichuan: Non-contentious, Chambers and Partners Greater China Region
• 2023, Recommended firm in Corporate/Commercial: Guangdong, Chambers and Partners Greater China Region
• 2012-2021, Recommended firm in Corporate/M&A, Chambers and Partners Asia Pacific
• 2019-2025, Recommended firm in Corporate/M&A, Chambers and Partners Global
• 2008-2011, Highly Recommended firm in Corporate and M&A, Chambers and Partners Asia Pacific
• 2011-2025, Recommended firm in Corporate and M&A, The Legal 500 Asia Pacific
• 2001-2010, Top-tier firm in Corporate and M&A, The Legal 500 Asia Pacific
• 2024, China M&A Rankings – China Domestic (Tier 1), Asian Legal Business
• 2016-2023, China M&A Rankings – China Domestic (Tier 2), Asian Legal Business
• 2022-2024, Highly Recommended firm in Corporate and M&A, asialaw
• 2015-2021, Recommended firm in Corporate and M&A, asialaw
• 2016-2025, Recommended firm in M&A, IFLR1000
• 2022-2025, Recommended firm in M&A (Beijing & Shanghai), IFLR1000 China
• 2016-2024, Top-tier firm in Corporate M&A, LEGALBAND
• 2020-2024, Recommended firm: Commercial and transactions (Asia-Pacific Dispute Resolution List), Benchmark Litigation
• 2022-2024, Recommended firm: Beijing, Shanghai, Guangdong/Shenzhen, Sichuan/Chengdu - Commercial Disputes, (China Region Dispute Resolution List), Benchmark Litigation
• 2021, Recommended firm: Beijing, Shanghai, Shenzhen - Commercial and transactions (Benchmark Litigation China List), Benchmark Litigation
• 2020-2021, China Business Law Awards – “M & A (Outbound)”, China Business Law Journal
• 2022, Top 10 Best M&A Deals of the Last Decade: (1) SF Holdings' Back-door Listing of Maanshan Dingtai Rare Earth & New Materials Ltd; (2) Adamma’s Combination with Sanonda; (3) China Merchants' Highway Acquire Huabei Expressway, China Association for Public Companies
• 2010, Ranked eighth in the 2010 Asia-pacific Global Financial Advisory M&A Rankings and third in PRC firms (based on numbers of disclosed cases), Bloomberg Law